Skip to main content

Amicus Therapeutics(FOLD-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

CORRECTING AND REPLACING -- Amicus Therapeutics Announces First Quarter 2022 Financial Results

Globe Newswire - Mon May 9, 2022

1Q22 Galafold® Revenue Growth of 18.5% to $78.7M

New Composition of Matter Patent for Galafold® Strengthens U.S. Patent Protection into 2038

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe